JCI - Citations to Anticancer drug targets: approaching angiogenesis

Citations to this article

Anticancer drug targets: approaching angiogenesis

Eli Keshet, Shmuel A. Ben-Sasson

Eli Keshet, Shmuel A. Ben-Sasson

Published December 1, 1999
Citation Information: J Clin Invest. 1999;104(11):1497-1501. https://doi.org/10.1172/JCI8849.

View: Text | PDF

Total citations by year

Year:	2024	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	Total
Citations:	1	2	1	1	3	1	2	1	1	2	3	5	4	6	2	4	3	2	8	10	10	9	7	88

Citation information

Citations to this article (88)

Title and authors	Publication	Year
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study Trotta MC, Gesualdo C, Lepre CC, Russo M, Ferraraccio F, Panarese I, Marano E, Grieco P, Petrillo F, Hermenean A, Simonelli F, D\u2019Amico M, Bucolo C, Lazzara F, De Nigris F, Rossi S, Platania CB	Frontiers in pharmacology	2024
Chimaphila umbellata extract exerts anti-proliferative effect on human breast cancer cells via RIP1K/RIP3K-mediated necroptosis N Das, S Samantaray, C Ghosh, K Kushwaha, D Sircar, P Roy		2021
Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling M El-Sherbiny, RM El-Sayed, MA Helal, AT Ibrahiem, HS Elmahdi, MA Eladl, SE Bilay, AM Alshahrani, MK Tawfik, ZE Hamed, AO Mohamed, SA Zaitone	Molecules (Basel, Switzerland)	2021
Advances in Metallodrugs: Preparation and Applications in Medicinal Chemistry ShahidulIslam, AA Hashmi, SA Khan		2020
Synthesis and Screening of Pro-apoptotic and Angio-inhibitory Activity of Novel Benzisoxazole Derivatives both In Vitro and In Vivo S Byrappa, K Rachaiah, SY Kotian, Y Balaraju, SC Prabhuswamimath, KM Rai, BP Salimath	Anti-cancer agents in medicinal chemistry	2019
Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer V Veenstra, A Garcia-Garijo, H van Laarhoven, M Bijlsma	Cancers	2018
Zerumbone Suppresses Angiogenesis in HepG2 Cells through Inhibition of Matrix Metalloproteinase-9, Vascular Endothelial Growth Factor, and Vascular Endothelial Growth Factor Receptor Expressions Nozlena Abdul Samad, Ahmad Bustamam Abdul, Heshu Sulaiman Rahman, Abdullah Rasedee, Tengku Azmi Tengku Ibrahim, Yeap Swee Keon	Pharmacognosy magazine	2018
A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors F Wang, J Molina, D Satele, J Yin, VS Lim, AA Adjei	Investigational New Drugs	2018
A new acridine derivative induces cell cycle arrest and antiangiogenic effect on Ehrlich ascites carcinoma model VM Mangueira, TM Batista, MT Brito, TK de Sousa, RM da Cruz, RA de Abrantes, RC Veras, IA de Medeiros, KK de Medeiros, AL da Pereira, VL Serafim, RO de Moura, MV Sobral	Biomedicine & Pharmacotherapy	2017
The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha: TARGETING IL-1 ALPHA IN HUMAN SKIN DISEASES MJ Bou-Dargham, ZI Khamis, AB Cognetta, QX Sang	Medicinal Research Reviews	2016
Wnt Signaling in Renal Cell Carcinoma Q Xu, M Krause, A Samoylenko, S Vainio	Cancers	2016
Antiangiogenesis, Loss of Cell Adhesion and Apoptosis Are Involved in Antitumoral Activity of Proteases in Murine Melanoma B16F1 V. cundinamarcensis (C. candamarcensis) D Dittz, C Figueiredo, F Lemos, C Viana, S Andrade, E Souza-Fagundes, R Fujiwara, C Salas, M Lopes	International journal of molecular sciences	2015
Anti-proliferative and angio-suppressive effect of Stoechospermum marginatum (C. Agardh) Kutzing extract using various experimental models R Vinayak, S Puttananjaiah, A Chatterji, B Salimath	Nutrition Research and Practice	2014
Enhancement of Angiogenesis by a 27 kDa Lectin from Perivitelline Fluid of Horseshoe Crab Embryos through Upregulation of VEGF and Its Receptor KL Surekha, M Waghchoude, S Ghaskadbi	Journal of Natural Products	2013
Marine Biomaterials: Characterization, Isolation and Applications P Sen	Marine Biomaterials: Characterization, Isolation and Applications	2013
Methods in Enzymology JD Stone, AS Chervin, DH Aggen, DM Kranz	Protein Engineering for Therapeutics Part B	2012
Plant-Derived Natural Products Research in Drug Discovery KH Lee, H Itokawa, T Akiyama, SL Morris-Natschke	Natural Products in Chemical Biology Civjan/Natural Products in Chemical Biology	2012
Beyond Antiangiogenesis: Vascular Modulation as an Anticancer Therapy—A Review BT Oronsky, JJ Scicinski, T Reid, S Knox	Translational oncology	2012
Structural Modification of Honokiol, a Biphenyl Occurring in Magnolia officinalis: the Evaluation of Honokiol Analogues as Inhibitors of Angiogenesis and for Their Cytotoxicity and Structure–Activity Relationship L Ma, J Chen, X Wang, X Liang, Y Luo, W Zhu, T Wang, M Peng, S Li, S Jie, A Peng, Y Wei, L Chen	Journal of Medicinal Chemistry	2011
Bevacizumab-Induced Hypertension KN Syrigos, E Karapanagiotou, P Boura, C Manegold, K Harrington	BioDrugs	2011
Annual Reports in Medicinal Chemistry JJ Liu, TW Lee	Annual Reports in Medicinal Chemistry Volume 46	2011
Production and Characterization of a Humanized Single-chain Antibody against Human Integrin αvβ3 Protein* D Liu, C Wang, C Li, X Zhang, B Zhang, Z Mi, X An, Y Tong	The Journal of biological chemistry	2011
Production and Characterization of a Humanized Single-chain Antibody against Human Integrin αvβ3 Protein D Liu, C Wang, C Li, X Zhang, B Zhang, Z Mi, X An, Y Tong	The Journal of biological chemistry	2011
Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis AG Linkous, EM Yazlovitskaya, DE Hallahan	JNCI Journal of the National Cancer Institute	2010
Blockade of Delta-Like Ligand 4 Signaling Inhibits Both Growth and Angiogenesis of Pancreatic Cancer H Oishi, M Sunamura, S Egawa, F Motoi, M Unno, T Furukawa, NA Habib, H Yagita	Pancreas	2010
Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray HS Kim, YH Park, J Lee, JS Ahn, J Kim, YM Shim, JH Kim, K Park, J Han, MJ Ahn	Cancer	2010
Therapeutic Angiogenesis for Vascular Diseases M Slevin		2010
Topography of extracellular matrix mediates vascular morphogenesis and migration speeds in angiogenesis AL Bauer, TL Jackson, Y Jiang	PLoS computational biology	2009
Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery QH Zhao, Y Zhang, Y Liu, HL Wang, YY Shen, WJ Yang, LP Wen	Medical Oncology	2009
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide D Leali, R Bianchi, A Bugatti, S Nicoli, S Mitola, L Ragona, S Tomaselli, G Gallo, S Catello, V Rivieccio, L Zetta, M Presta	Journal of Cellular and Molecular Medicine	2009
New avenues for second-line treatment of metastatic non-small-cell lung cancer C Gridelli, P Maione, A Rossi, M Falanga, M Bareschino, C Schettino, G Colantuoni, C Guerriero, D Nicolella, E Rossi, ML Ferrara, G Palazzolo	Expert Review of Anticancer Therapy	2009
Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines V Stupáková, L Varinská, A Miroššay, M Šarišský, J Mojžiš, R Dankovčík, P Urdzík, A Ostró, L Mirossay	Phytotherapy Research	2009
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity M Rusnati, A Bugatti, S Mitola, D Leali, P Bergese, LE Depero, M Presta	Sensors (Basel, Switzerland)	2009
Wiley Encyclopedia of Chemical Biology R Bittman	Wiley Encyclopedia of Chemical Biology	2008
Expression of the Anti-apoptotic Factors Bcl-2 and Survivin in Canine Vascular Tumours M Murakami, H Sakai, A Kodama, T Mori, K Maruo, T Yanai, T Masegi	Journal of Comparative Pathology	2008
Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo FM Klenke, A Abdollahi, E Bertl, MM Gebhard, V Ewerbeck, PE Huber, A Sckell	BMC Cancer	2007
Endostatin: Current concepts about its biological role and mechanisms of action AV Digtyar, NV Pozdnyakova, NB Feldman, SV Lutsenko, SE Severin	Biochemistry (Moscow)	2007
Oxygen Transport to Tissue XXVIII DJ Maguire, DF Bruley, DK Harrison		2007
The Role of Bevacizumab in the Treatment of Non‐Small Cell Lung Cancer: Current Indications and Future Developments C Gridelli, P Maione, A Rossi, FD Marinis	The oncologist	2007
New antiangiogenetic agents and non-small cell lung cancer C Gridelli, A Rossi, P Maione	Critical Reviews in Oncology/Hematology	2006
The Anti-angiogenic Activity of rPAI-1 23 Inhibits Fibroblast Growth Factor-2 Functions M Drinane, J Walsh, J Mollmark, M Simons, MJ Mulligan-Kehoe	The Journal of biological chemistry	2006
Role of endothelial cell apoptosis in regulation of skeletal muscle angiogenesis during high and low salt intake MM de Resende, SL Amaral, DH Munzenmaier, AS Greene	Physiological genomics	2006
Mathematical modelling of flow in 2D and 3D vascular networks: Applications to anti-angiogenic and chemotherapeutic drug strategies A Stéphanou, SR McDougall, AR Anderson, MA Chaplain	Mathematical and Computer Modelling	2005
Antiangiogenic and Vascular-Targeting Activity of the Microtubule-Destabilizing trans -Resveratrol Derivative 3,5,4′-Trimethoxystilbene M Belleri, D Ribatti, S Nicoli, F Cotelli, L Forti, V Vannini, LA Stivala, M Presta	Molecular pharmacology	2005
Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment P Sonveaux, C Dessy, P Martinive, X Havaux, BF Jordan, B Gallez, V Grégoire, JL Balligand, O Feron	Cancer research	2004
The role of targeted therapy in non-small cell lung cancer P Maione, A Rossi, G Airoma, C Ferrara, V Castaldo, C Gridelli	Critical Reviews in Oncology/Hematology	2004
Cytoskeletal Rearrangement and Caspase Activation in Sphingosine 1-Phosphate-Induced Lung Capillary Tube Formation LA Linz-McGillem, J Moitra, JG Garcia	Stem Cells and Development	2004
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium S Donnini, L Morbidelli, G Taraboletti, M Ziche	Life Sciences	2004
Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model A Maataoui, J Qian, D Vossoughi, MF Khan, E Oppermann, WO Bechstein, TJ Vogl	European Radiology	2004
Growth Factors and their Receptors in Cancer Metastasis CR Snyder, WG Jiang, K Matsumoto, T Nakamura		2004
Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate A Herzog, U Siler, V Spitzer, N Seifert, A Denelavas, PB Hunziker, W Hunziker, R Goralczyk, K Wertz	The FASEB Journal	2004
Evaluation of 64 Cu- and 125 I-Radiolabeled Bitistatin as Potential Agents for Targeting α v β 3 Integrins in Tumor Angiogenesis P McQuade, LC Knight, MJ Welch	Bioconjugate Chemistry	2004
IL-1 is required for tumor invasiveness and angiogenesis E Voronov, DS Shouval, Y Krelin, E Cagnano, D Benharroch, Y Iwakura, CA Dinarello, RN Apte	Proceedings of the National Academy of Sciences	2003
Suppression of tumor growth by a new glycosaminoglycan isolated from the African giant snail Achatina fulica YS Lee, HO Yang, KH Shin, HS Choi, SH Jung, YM Kim, DK Oh, RJ Linhardt, YS Kim	European Journal of Pharmacology	2003
Vascular Endothelial Growth Factor Expression, β-Catenin Tyrosine Phosphorylation, and Endothelial Proliferative Behavior: A Pathway for Transformation? N Ilan, A Tucker, JA Madri	Laboratory Investigation	2003
Combined interventional therapies of hepatocellular carcinoma J Qian	World journal of gastroenterology : WJG	2003
Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents C Gridelli, A Rossi, P Maione	Oncogene	2003
Apoptotic cues from the extracellular matrix: regulators of angiogenesis DG Stupack, DA Cheresh	Oncogene	2003
Angiostatin and hepatocellular carcinoma G Soff	Hepatology	2003
Angiostatin: A Negative Regulator of Endothelial-Dependent Vasodilation R Koshida, J Ou, T Matsunaga, WM Chilian, KT Oldham, AW Ackerman, KA Pritchard	Circulation	2003
Plasminogen: Structure, Activation, and Regulation DM Waisman		2003
Combined interventional therapies of hepatocellular carcinoma. Qian J, Feng GS, Vogl T	World Journal of Gastroenterology	2003
Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks OC Velazquez, R Snyder, ZJ Liu, RM Fairman, M Herlyn	The FASEB Journal	2002
Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis C Mailhos, U Modlich, J Lewis, A Harris, R Bicknell, D Ish-Horowicz	Differentiation; research in biological diversity	2002
Perindopril: possible use in cancer therapy H Yoshiji, S Kuriyama, H Fukui	Anti-Cancer Drugs	2002
THE MOLECULAR CONTROL OF ANGIOGENESIS O Distler, M Neidhart, RE Gay, S Gay	International Reviews of Immunology	2002
A doxorubicin–CNGRC-peptide conjugate with prodrug properties Y Hensbergen, HJ Broxterman, YW Elderkamp, J Lankelma, JC Beers, M Heijn, E Boven, K Hoekman, HM Pinedo	Biochemical Pharmacology	2002
Molecular basis of the VHL hereditary cancer syndrome WG Kaelin	Nature Reviews Cancer	2002
Novel Targets for Lung Cancer Therapy: Part II GK Dy, AA Adjei	Journal of Clinical Oncology	2002
Anti-angiogenic activity of the purine analog 6-thioguanine M Presta, M Belleri, A Vacca, D Ribatti	Leukemia	2002
Induction of Apoptosis of Endothelial Cells by Viscum album: A Role for Anti-Tumoral Properties of Mistletoe Lectins JP Huyen, J Bayry, S Delignat, AT Gaston, O Michel, P Bruneval, MD Kazatchkine, A Nicoletti, SV Kaveri	Molecular Medicine	2002
The New Angiotherapy TP Fan, EC Kohn		2002
Antiangiogenic agents and their promising potential in combined therapy PA Burke, SJ DeNardo	Critical Reviews in Oncology/Hematology	2001
Novel pharmacological agents in clinical development for solid tumours GK Dy, P Haluska, AA Adjei	Expert Opinion on Investigational Drugs	2001
Quantification of angiogenesis stimulators in children with solid malignancies H Pavlakovic, VV Sch�tz, J R�ssler, E Koscielniak, W Havers, L Schweigerer	International Journal of Cancer	2001
Kinetics of tumorigenic vascular endothelial growth factor signalling and its significance in human hepatocellular carcinoma cells Y Fang, M Hu, K Liu	Biomedecine & Pharmacotherapy	2001
ANTIANGIOGENESIS THERAPY MW Kieran, A Billett	Hematology/Oncology Clinics of North America	2001
Blood Vessels are Regulators of Growth, Diagnostic Markers and Therapeutic Targets in Prostate Cancer IF J	Scandinavian Journal of Urology and Nephrology	2001
Tissue-specific gene therapy directed to tumor angiogenesis N Varda-Bloom, A Shaish, A Gonen, K Levanon, S Greenbereger, S Ferber, H Levkovitz, D Castel, I Goldberg, A Afek, Y Kopolovitc, D Harats	Gene Therapy	2001
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis MS Pepper	Arteriosclerosis, thrombosis, and vascular biology	2001
Fibroblast Growth Factor-2 Antagonist Activity and Angiostatic Capacity of Sulfated Escherichia coli K5 Polysaccharide Derivatives D Leali, M Belleri, C Urbinati, D Coltrini, P Oreste, G Zoppetti, D Ribatti, M Rusnati, M Presta	The Journal of biological chemistry	2001
Monoclonal antibodies and therapy of human cancers A Funaro	Biotechnology Advances	2000
Approach to pulmonary metastases KY Yoneda, S Louie, DK Shelton	Current Opinion in Pulmonary Medicine	2000
Tissue selective affinity targeting using the avidin-biotin system L Chen, B Schechter, R Arnon, M Wilchek	Drug Development Research	2000
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF) RA Mitchell, R Bucala	Seminars in Cancer Biology	2000
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression GL Semenza	Critical Reviews in Biochemistry and Molecular Biology	2000
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression M Elkin, HQ Miao, A Nagler, E Aingorn, R Reich, I Hemo, HL Dou, M Pines, I Vlodavsky	The FASEB Journal	2000
Mechanism-Based Target Identification and Drug Discovery in Cancer Research JB Gibbs	Science	2000

Advertisement